Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Comecer is an Italian life sciences equipment company that designs, manufactures, and services high-technology aseptic processing and containment systems for the pharmaceutical, radiopharmaceutical, nuclear medicine, and ATMP/cell and gene therapy markets. Its portfolio includes isolators, hot cells, dispensing and fill-finish systems, shielded equipment, dose calibrators, software, and related support services used in highly regulated healthcare manufacturing environments. The company is particularly well known for radiopharma and nuclear medicine infrastructure, including systems for handling, dispensing, and producing radiopharmaceuticals under GMP conditions. Founded in 1975 and headquartered in Castel Bolognese, Italy, Comecer operates internationally and has been part of ATS Corporation's Life Sciences Group since March 1, 2019. Rather than developing therapeutics itself, Comecer supplies enabling manufacturing and containment technologies to hospitals, research centers, and pharma and radiopharma producers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Comecer.